Neuropace Inc (NPCE) is a Healthcare · Medical Devices company listed on NASDAQ. Price $14.50 (+2.47%), Market cap $0.55B, 52-week low–high $8.25 ~ $19.29.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded
Financial statements, price targets, institutional (13F) holdings and related news for Neuropace Inc are updated in real time on BlackAll Trade.
Neuropace Inc trades at $14.50 (+2.47%). Real-time quotes and charts are available on BlackAll Trade.
Neuropace Inc has a market cap of about $0.55B.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at